179 related articles for article (PubMed ID: 22685015)
1. Hepatitis C virus NS3/4A protease blocks IL-28 production.
Ding Q; Huang B; Lu J; Liu YJ; Zhong J
Eur J Immunol; 2012 Sep; 42(9):2374-82. PubMed ID: 22685015
[TBL] [Abstract][Full Text] [Related]
2. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.
Johnson CL; Owen DM; Gale M
J Biol Chem; 2007 Apr; 282(14):10792-803. PubMed ID: 17289677
[TBL] [Abstract][Full Text] [Related]
3. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of IFN-λ genes in hepatitis C virus-infected hepatocytes via IRF-3·IRF-7·NF-κB complex.
Lee HC; Narayanan S; Park SJ; Seong SY; Hahn YS
J Biol Chem; 2014 Feb; 289(8):5310-9. PubMed ID: 24385435
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity.
Ding Q; Cao X; Lu J; Huang B; Liu YJ; Kato N; Shu HB; Zhong J
J Hepatol; 2013 Jul; 59(1):52-8. PubMed ID: 23542348
[TBL] [Abstract][Full Text] [Related]
6. HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.
Thomas E; Gonzalez VD; Li Q; Modi AA; Chen W; Noureddin M; Rotman Y; Liang TJ
Gastroenterology; 2012 Apr; 142(4):978-88. PubMed ID: 22248663
[TBL] [Abstract][Full Text] [Related]
7. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
[TBL] [Abstract][Full Text] [Related]
8. Interferon-lambda serum levels in hepatitis C.
Langhans B; Kupfer B; Braunschweiger I; Arndt S; Schulte W; Nischalke HD; Nattermann J; Oldenburg J; Sauerbruch T; Spengler U
J Hepatol; 2011 May; 54(5):859-65. PubMed ID: 21145813
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
[TBL] [Abstract][Full Text] [Related]
10. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.
Desai MM; Gong B; Chan T; Davey RA; Soong L; Kolokoltsov AA; Sun J
Gastroenterology; 2011 Aug; 141(2):674-85, 685.e1-6. PubMed ID: 21683701
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage.
Welsch C; Haselow K; Gouttenoire J; Schneider M; Morikawa K; Martinez Y; Susser S; Sarrazin C; Zeuzem S; Antes I; Moradpour D; Lange CM
J Hepatol; 2015 Apr; 62(4):779-84. PubMed ID: 25463536
[TBL] [Abstract][Full Text] [Related]
12. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
13. Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.
Brownell J; Bruckner J; Wagoner J; Thomas E; Loo YM; Gale M; Liang TJ; Polyak SJ
J Virol; 2014 Feb; 88(3):1582-90. PubMed ID: 24257594
[TBL] [Abstract][Full Text] [Related]
14. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
15. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
Zhang S; Kodys K; Li K; Szabo G
Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
[TBL] [Abstract][Full Text] [Related]
16. Viral infections activate types I and III interferon genes through a common mechanism.
Onoguchi K; Yoneyama M; Takemura A; Akira S; Taniguchi T; Namiki H; Fujita T
J Biol Chem; 2007 Mar; 282(10):7576-81. PubMed ID: 17204473
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
20. Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
Horner SM; Park HS; Gale M
J Virol; 2012 Mar; 86(6):3112-20. PubMed ID: 22238314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
